Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly medicine.